Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 36 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-28 KENNEY CHRISTOPHER JOHN Chief Medical Officer Sale 10b5-1 −6,368 $60.17 $383K 702
2026-08-28 KENNEY CHRISTOPHER JOHN Chief Medical Officer Sale 10b5-1 −700 $60.98 $43K 2
2026-03-13 KENNEY CHRISTOPHER JOHN Chief Medical Officer Sale 10b5-1 −1,410 $55.23 $78K 7,069
2026-03-12 KENNEY CHRISTOPHER JOHN Chief Medical Officer Exercise or conversion 10b5-1 +3,750 8,479
2026-03-12 KENNEY CHRISTOPHER JOHN Chief Medical Officer Exercise or conversion · Restricted Share Units 10b5-1 −3,750 11,250
2026-03-10 KENNEY CHRISTOPHER JOHN Chief Medical Officer Sale 10b5-1 −2,771 $60.11 $167K 4,729
2026-03-09 KENNEY CHRISTOPHER JOHN Chief Medical Officer Exercise or conversion 10b5-1 +7,500 7,500
2026-03-09 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Performance Share Units 10b5-1 +7,500 7,500
2026-03-09 KENNEY CHRISTOPHER JOHN Chief Medical Officer Exercise or conversion · Performance Share Units 10b5-1 −7,500 0
2026-01-09 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Share Option (Right to Buy) +100,000 100,000
2026-01-09 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Restricted Share Units +20,000 20,000
2025-03-12 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Share Option (Right to Buy) +80,000 80,000
2025-03-12 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Restricted Share Units +15,000 15,000
2024-03-11 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2023-03-24 KENNEY CHRISTOPHER JOHN Chief Medical Officer Sale −700 $35.01 $25K 0
2023-03-10 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000
2022-03-10 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2022-01-21 KENNEY CHRISTOPHER JOHN Chief Medical Officer Purchase +700 $28.81 $20K 700
2021-08-23 KENNEY CHRISTOPHER JOHN Chief Medical Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000

Page 1 of 1 · 19 trades